Products
We are actively taking measures to improve product quality levels.
Applications
Why Hamamatsu?
Resources
Support
Our company
Investors
United States (EN)
Select your region or country.
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
- Hamamatsu Corporation
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated, end-to-end solution for digital pathology that brings together best-in-class products from Agilent, Visiopharm, Proscia®, and Hamamatsu. The announcement coincides with the USCAP 112th Annual Meeting held March 11-16 at the New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana.
The increasing prevalence of chronic conditions is predicted to intensify the urgency of pathologists seeking to adopt innovative digital pathology solutions to improve existing patient diagnostic imaging methods and reduce the high cost associated with traditional diagnostics. Technological advances in the past decade and the numerous benefits of digital pathology are driving the practice to rapidly become widely adopted.
Agilent and Visiopharm have been collaborators since 2020, developing an integrated solution comprising Visiopharm’s portfolio of leading artificial intelligence (AI)-driven precision pathology software and Agilent’s automated pathology staining solutions. The collaboration also includes a distribution agreement, initially in Europe but now expanded to include the US and Canada. Agilent and Visiopharm have also broadened their development services to include digital pathology applications that will increasingly benefit the global pharmaceutical industry by providing access to Visiopharm’s AI capabilities to deliver innovative, high-quality companion diagnostics.
“Agilent has meticulously and diligently been working toward the development of a complete end-to-end digital pathology solution to help pathology labs increase efficiency, clinical utility, quality control, and ultimately patient care,” said Lou Welebob, vice president and general manager of Agilent’s Pathology division, Diagnostics and Genomics Group.
“Our objective was to work with industry innovators, starting with Visiopharm as our initial partner. We are now excited to announce that we have expanded our offering through the addition of two additional partners Proscia and Hamamatsu, in this fast-growing digital pathology space,” Welebob added.
“Together, we have enabled pathologists worldwide to improve patient care through the integration of our AI-driven precision pathology software and Agilent’s automated staining solutions, said Michael Grunkin, CEO of Visiopharm. “We are delighted to further extend our partnership in this emerging era of personalized medicine.”
The recent announcements include Proscia, a leader in digital pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems. The technology combination of Agilent, Visiopharm, Proscia, and Hamamatsu strengthens the development of an open and agnostic end-to-end digital pathology solution with the vision of accelerating breakthroughs in precision medicine.
USCAP attendees are invited to visit Agilent’s exhibition booth #129 and learn about these partnerships, products, and solutions. Agilent is also bringing together partners and industry thought leaders to discuss the future of cancer care and how an open, agnostic system can dramatically change the future of cancer care. Presenters will include Alan Byrne, Principal Global Product Manager, Digital Pathology, Agilent Technologies; David West, CEO of Proscia; Saira Shah, M.D., Physician Pathologist and Breast Consultant Pathologist at Quest Diagnostics; Martin Kristensson, Senior Vice President, Global Clinical Sales, Visiopharm; and Giovanni Lujan, M.D., Director of Digital and Computational Pathology at Ohio State University. Additional information about this event will be available at the Agilent booth.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.
- Confirmation
-
It looks like you're in the . If this is not your location, please select the correct region or country below.
You're headed to Hamamatsu Photonics website for US (English). If you want to view an other country's site, the optimized information will be provided by selecting options below.
In order to use this website comfortably, we use cookies. For cookie details please see our cookie policy.
- Cookie Policy
-
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in this cookie policy. By closing the cookie warning banner, scrolling the page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.
Hamamatsu uses cookies in order to enhance your experience on our website and ensure that our website functions.
You can visit this page at any time to learn more about cookies, get the most up to date information on how we use cookies and manage your cookie settings. We will not use cookies for any purpose other than the ones stated, but please note that we reserve the right to update our cookies.
1. What are cookies?
For modern websites to work according to visitor’s expectations, they need to collect certain basic information about visitors. To do this, a site will create small text files which are placed on visitor’s devices (computer or mobile) - these files are known as cookies when you access a website. Cookies are used in order to make websites function and work efficiently. Cookies are uniquely assigned to each visitor and can only be read by a web server in the domain that issued the cookie to the visitor. Cookies cannot be used to run programs or deliver viruses to a visitor’s device.
Cookies do various jobs which make the visitor’s experience of the internet much smoother and more interactive. For instance, cookies are used to remember the visitor’s preferences on sites they visit often, to remember language preference and to help navigate between pages more efficiently. Much, though not all, of the data collected is anonymous, though some of it is designed to detect browsing patterns and approximate geographical location to improve the visitor experience.
Certain type of cookies may require the data subject’s consent before storing them on the computer.
2. What are the different types of cookies?
This website uses two types of cookies:
- First party cookies. For our website, the first party cookies are controlled and maintained by Hamamatsu. No other parties have access to these cookies.
- Third party cookies. These cookies are implemented by organizations outside Hamamatsu. We do not have access to the data in these cookies, but we use these cookies to improve the overall website experience.
3. How do we use cookies?
This website uses cookies for following purposes:
- Certain cookies are necessary for our website to function. These are strictly necessary cookies and are required to enable website access, support navigation or provide relevant content. These cookies direct you to the correct region or country, and support security and ecommerce. Strictly necessary cookies also enforce your privacy preferences. Without these strictly necessary cookies, much of our website will not function.
- Analytics cookies are used to track website usage. This data enables us to improve our website usability, performance and website administration. In our analytics cookies, we do not store any personal identifying information.
- Functionality cookies. These are used to recognize you when you return to our website. This enables us to personalize our content for you, greet you by name and remember your preferences (for example, your choice of language or region).
- These cookies record your visit to our website, the pages you have visited and the links you have followed. We will use this information to make our website and the advertising displayed on it more relevant to your interests. We may also share this information with third parties for this purpose.
Cookies help us help you. Through the use of cookies, we learn what is important to our visitors and we develop and enhance website content and functionality to support your experience. Much of our website can be accessed if cookies are disabled, however certain website functions may not work. And, we believe your current and future visits will be enhanced if cookies are enabled.
4. Which cookies do we use?
There are two ways to manage cookie preferences.
- You can set your cookie preferences on your device or in your browser.
- You can set your cookie preferences at the website level.
If you don’t want to receive cookies, you can modify your browser so that it notifies you when cookies are sent to it or you can refuse cookies altogether. You can also delete cookies that have already been set.
If you wish to restrict or block web browser cookies which are set on your device then you can do this through your browser settings; the Help function within your browser should tell you how. Alternatively, you may wish to visit www.aboutcookies.org, which contains comprehensive information on how to do this on a wide variety of desktop browsers.
5. What are Internet tags and how do we use them with cookies?
Occasionally, we may use internet tags (also known as action tags, single-pixel GIFs, clear GIFs, invisible GIFs and 1-by-1 GIFs) at this site and may deploy these tags/cookies through a third-party advertising partner or a web analytical service partner which may be located and store the respective information (including your IP-address) in a foreign country. These tags/cookies are placed on both online advertisements that bring users to this site and on different pages of this site. We use this technology to measure the visitors' responses to our sites and the effectiveness of our advertising campaigns (including how many times a page is opened and which information is consulted) as well as to evaluate your use of this website. The third-party partner or the web analytical service partner may be able to collect data about visitors to our and other sites because of these internet tags/cookies, may compose reports regarding the website’s activity for us and may provide further services which are related to the use of the website and the internet. They may provide such information to other parties if there is a legal requirement that they do so, or if they hire the other parties to process information on their behalf.
If you would like more information about web tags and cookies associated with on-line advertising or to opt-out of third-party collection of this information, please visit the Network Advertising Initiative website http://www.networkadvertising.org.
6. Analytics and Advertisement Cookies
We use third-party cookies (such as Google Analytics) to track visitors on our website, to get reports about how visitors use the website and to inform, optimize and serve ads based on someone's past visits to our website.
You may opt-out of Google Analytics cookies by the websites provided by Google:
https://tools.google.com/dlpage/gaoptout?hl=en
As provided in this Privacy Policy (Article 5), you can learn more about opt-out cookies by the website provided by Network Advertising Initiative:
http://www.networkadvertising.org
We inform you that in such case you will not be able to wholly use all functions of our website.
Close